Pitching A Stent Amid The Hype: Cypher, Taxus Programs In 2003 And Beyond

Patient and physician demand for drug-eluting stents in the U.S. has played an inimitable role in shaping the cardiovascular device market over the past year - and has set the stage for a stirring competition between the Cypher and Taxus stents